Close

Drug Research

Russia Begins Sputnik V Coronavirus Vaccine Distribution

Sputnik V has been rolled out in Moscow and will be subsequently distributed across other Russian cities. One needs to see if this...

KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus

KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing agreement for the research, development, and commercialization of VET2-L2,...

Catalent to Invest $10 Million to Expand High Potency Containment Capabilities for Micronization

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab for COVID-19

Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently...

Rush For A COVID Vaccine- Is It Science Or Politics…?

COVID-19 vaccine usage announcement by the UK has brought us to the brink where other countries too might jump on the bandwagon. Is it...

Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate

KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing...

ViGeneron and WuXi AppTec Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read